BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 26991123)

  • 1. MiRNA-Related Genetic Variations Associated with Radiotherapy-Induced Toxicities in Patients with Locally Advanced Non-Small Cell Lung Cancer.
    Li R; Pu X; Chang JY; Ye Y; Komaki R; Minna JD; Roth JA; Han B; Wu X
    PLoS One; 2016; 11(3):e0150467. PubMed ID: 26991123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variants in inflammation-related genes are associated with radiation-induced toxicity following treatment for non-small cell lung cancer.
    Hildebrandt MA; Komaki R; Liao Z; Gu J; Chang JY; Ye Y; Lu C; Stewart DJ; Minna JD; Roth JA; Lippman SM; Cox JD; Hong WK; Spitz MR; Wu X
    PLoS One; 2010 Aug; 5(8):e12402. PubMed ID: 20811626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variants of the LIN28B gene predict severe radiation pneumonitis in patients with non-small cell lung cancer treated with definitive radiation therapy.
    Wen J; Liu H; Wang Q; Liu Z; Li Y; Xiong H; Xu T; Li P; Wang LE; Gomez DR; Mohan R; Komaki R; Liao Z; Wei Q
    Eur J Cancer; 2014 Jul; 50(10):1706-1716. PubMed ID: 24780874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of miR-125a expression by rs12976445 single-nucleotide polymorphism is associated with radiotherapy-induced pneumonitis in lung carcinoma patients.
    Huang X; Zhang T; Li G; Guo X; Liu X
    J Cell Biochem; 2019 Mar; 120(3):4485-4493. PubMed ID: 30302847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiotherapy or chemotherapy followed by radiotherapy with or without amifostine in locally advanced lung cancer.
    Antonadou D
    Semin Radiat Oncol; 2002 Jan; 12(1 Suppl 1):50-8. PubMed ID: 11917285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amifostine reduces radiochemotherapy-induced toxicities in patients with locally advanced non-small cell lung cancer.
    Antonadou D; Petridis A; Synodinou M; Throuvalas N; Bolanos N; Veslemes M; Sagriotis A
    Semin Oncol; 2003 Dec; 30(6 Suppl 18):2-9. PubMed ID: 14727235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentially Functional Variants of ATG16L2 Predict Radiation Pneumonitis and Outcomes in Patients with Non-Small Cell Lung Cancer after Definitive Radiotherapy.
    Wen J; Liu H; Wang L; Wang X; Gu N; Liu Z; Xu T; Gomez DR; Komaki R; Liao Z; Wei Q
    J Thorac Oncol; 2018 May; 13(5):660-675. PubMed ID: 29454863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variants of the nonhomologous end joining gene LIG4 and severe radiation pneumonitis in nonsmall cell lung cancer patients treated with definitive radiotherapy.
    Yin M; Liao Z; Liu Z; Wang LE; O'Reilly M; Gomez D; Li M; Komaki R; Wei Q
    Cancer; 2012 Jan; 118(2):528-35. PubMed ID: 21717429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between Genetic Variants in DNA Double-Strand Break Repair Pathways and Risk of Radiation Therapy-Induced Pneumonitis and Esophagitis in Non-Small Cell Lung Cancer.
    Zhao L; Pu X; Ye Y; Lu C; Chang JY; Wu X
    Cancers (Basel); 2016 Feb; 8(2):. PubMed ID: 26901225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation-related genetic variants predict toxicity following definitive radiotherapy for lung cancer.
    Pu X; Wang L; Chang JY; Hildebrandt MA; Ye Y; Lu C; Skinner HD; Niu N; Jenkins GD; Komaki R; Minna JD; Roth JA; Weinshilboum RM; Wu X
    Clin Pharmacol Ther; 2014 Nov; 96(5):609-15. PubMed ID: 25054431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of amifostine on toxicities associated with radiochemotherapy in patients with locally advanced non-small-cell lung cancer.
    Antonadou D; Throuvalas N; Petridis A; Bolanos N; Sagriotis A; Synodinou M
    Int J Radiat Oncol Biol Phys; 2003 Oct; 57(2):402-8. PubMed ID: 12957251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms in BMP2/BMP4, with estimates of mean lung dose, predict radiation pneumonitis among patients receiving definitive radiotherapy for non-small cell lung cancer.
    Yang J; Xu T; Gomez DR; Yuan X; Nguyen QN; Jeter M; Song Y; Hahn S; Liao Z
    Oncotarget; 2017 Jun; 8(26):43080-43090. PubMed ID: 28574846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms of the vascular endothelial growth factor gene and severe radiation pneumonitis in non-small cell lung cancer patients treated with definitive radiotherapy.
    Yin M; Liao Z; Yuan X; Guan X; O'Reilly MS; Welsh J; Wang LE; Wei Q
    Cancer Sci; 2012 May; 103(5):945-50. PubMed ID: 22320189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Toxicity Between Intensity-Modulated Radiotherapy and 3-Dimensional Conformal Radiotherapy for Locally Advanced Non-small-cell Lung Cancer.
    Ling DC; Hess CB; Chen AM; Daly ME
    Clin Lung Cancer; 2016 Jan; 17(1):18-23. PubMed ID: 26303127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimized radiotherapy to improve clinical outcomes for locally advanced lung cancer.
    Jaksic N; Chajon E; Bellec J; Corre R; Ricordel C; de Latour B; Lena H; Schick U; de Crevoisier R; Castelli J
    Radiat Oncol; 2018 Aug; 13(1):147. PubMed ID: 30103774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response, toxicity, failure patterns, and survival in five Radiation Therapy Oncology Group (RTOG) trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non-small-cell carcinoma of the lung.
    Byhardt RW; Scott C; Sause WT; Emami B; Komaki R; Fisher B; Lee JS; Lawton C
    Int J Radiat Oncol Biol Phys; 1998 Oct; 42(3):469-78. PubMed ID: 9806503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concurrent two-dimensional radiotherapy and weekly docetaxel in the treatment of stage III non-small cell lung cancer: a good local response but no good survival due to radiation pneumonitis.
    Onishi H; Kuriyama K; Yamaguchi M; Komiyama T; Tanaka S; Araki T; Nishikawa K; Ishihara H
    Lung Cancer; 2003 Apr; 40(1):79-84. PubMed ID: 12660011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of ethnic differences in TGFβ1 gene polymorphisms and effects on the risk of radiation pneumonitis in non-small-cell lung cancer.
    Niu X; Li H; Chen Z; Liu Y; Kan M; Zhou D; Li Z; Ye X; Shen S; Lv C; Lu S
    J Thorac Oncol; 2012 Nov; 7(11):1668-75. PubMed ID: 23059779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating microRNAs as biomarkers of radiation-induced cardiac toxicity in non-small-cell lung cancer.
    Hawkins PG; Sun Y; Dess RT; Jackson WC; Sun G; Bi N; Tewari M; Hayman JA; Kalemkerian GP; Gadgeel SM; Lawrence TS; Haken RKT; Matuszak MM; Kong FS; Schipper MJ; Jolly S
    J Cancer Res Clin Oncol; 2019 Jun; 145(6):1635-1643. PubMed ID: 30923943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment-related acute esophagitis for patients with locoregionally advanced non-small cell lung cancer treated with involved-field radiotherapy and concurrent chemotherapy.
    Bar-Ad V; Leiby B; Witek M; Xiao Y; Cui Y; Dai Y; Cao J; Axelrod R; Campling B; Both S; Werner-Wasik M
    Am J Clin Oncol; 2014 Oct; 37(5):433-7. PubMed ID: 23388558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.